It was found that the combined therapy with pyrotinib and chrysin apparently increased ZBTB16 level in tumor tissues (Fig. 6c); this effect could be reversed by miR-16-5p overexpression via its mimics, which is in high accordance with the results of in vitro assays. Here, ZBTB16 is linked to neoplasm.